Labcorp Holdings Inc. (LH) Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®

Labcorp Holdings Inc. (NYSE: LH) FY 2026 Other Release

Newsdesk: